GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Almujtama Alraida Medical Co (SAU:9592) » Definitions » ROE %

Almujtama Alraida Medical Co (SAU:9592) ROE % : 9.17% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Almujtama Alraida Medical Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Almujtama Alraida Medical Co's annualized net income for the quarter that ended in Dec. 2023 was ﷼11.4 Mil. Almujtama Alraida Medical Co's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was ﷼124.2 Mil. Therefore, Almujtama Alraida Medical Co's annualized ROE % for the quarter that ended in Dec. 2023 was 9.17%.

The historical rank and industry rank for Almujtama Alraida Medical Co's ROE % or its related term are showing as below:

SAU:9592' s ROE % Range Over the Past 10 Years
Min: 9.17   Med: 29.97   Max: 89.74
Current: 9.17

During the past 3 years, Almujtama Alraida Medical Co's highest ROE % was 89.74%. The lowest was 9.17%. And the median was 29.97%.

SAU:9592's ROE % is ranked better than
62.16% of 621 companies
in the Healthcare Providers & Services industry
Industry Median: 5.03 vs SAU:9592: 9.17

Almujtama Alraida Medical Co ROE % Historical Data

The historical data trend for Almujtama Alraida Medical Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almujtama Alraida Medical Co ROE % Chart

Almujtama Alraida Medical Co Annual Data
Trend Dec21 Dec22 Dec23
ROE %
89.74 29.97 9.17

Almujtama Alraida Medical Co Semi-Annual Data
Dec21 Dec22 Dec23
ROE % 89.74 29.97 9.17

Competitive Comparison of Almujtama Alraida Medical Co's ROE %

For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almujtama Alraida Medical Co's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's ROE % distribution charts can be found below:

* The bar in red indicates where Almujtama Alraida Medical Co's ROE % falls into.



Almujtama Alraida Medical Co ROE % Calculation

Almujtama Alraida Medical Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=11.393/( (118.595+129.784)/ 2 )
=11.393/124.1895
=9.17 %

Almujtama Alraida Medical Co's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Dec. 2022 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=11.393/( (118.595+129.784)/ 2 )
=11.393/124.1895
=9.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Almujtama Alraida Medical Co  (SAU:9592) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=11.393/124.1895
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(11.393 / 407.74)*(407.74 / 388.2115)*(388.2115 / 124.1895)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.79 %*1.0503*3.126
=ROA %*Equity Multiplier
=2.93 %*3.126
=9.17 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=11.393/124.1895
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (11.393 / 13.488) * (13.488 / 13.948) * (13.948 / 407.74) * (407.74 / 388.2115) * (388.2115 / 124.1895)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8447 * 0.967 * 3.42 % * 1.0503 * 3.126
=9.17 %

Note: The net income data used here is one times the annual (Dec. 2023) net income data. The Revenue data used here is one times the annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Almujtama Alraida Medical Co ROE % Related Terms

Thank you for viewing the detailed overview of Almujtama Alraida Medical Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Almujtama Alraida Medical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Main Street, P.O. Box 109474, Al-Hamadania District, Jeddah, SAU, 21351
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retail in pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia. The Company also has an electronic pharmacy through which sales are made online through the Company's website, including providing free delivery service to customers.

Almujtama Alraida Medical Co Headlines

No Headlines